Loading clinical trials...
Loading clinical trials...
A UGT1A1 Genotype-Guided Dosing Study of Irinotecan Administered in Combination With 5-Fluorouracil/Leucovorin (FOLFIRI) and Cetuximab as First-Line Therapy in RAS Wild-Type Metastatic Colorectal Cancer Patients
Conditions
Interventions
Cetuximab
Fluorouracil
+2 more
Locations
1
Italy
Centro di Riferimento Oncologico
Aviano, Italy
Start Date
June 1, 2015
Primary Completion Date
August 1, 2016
Completion Date
August 1, 2016
Last Updated
December 9, 2016
NCT04511039
NCT03844620
NCT03992456
NCT03337087
NCT04109924
NCT03707574
Lead Sponsor
University of Chicago
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions